vTv Therapeutics (VTVT) Price to Sales (2015 - 2026)

vTv Therapeutics has disclosed Price to Sales across 10 years of filings, most recently posting 13.36 for Q1 2026.

• In Q1 2026, Price to Sales changed N/A year-over-year to 13.36; the TTM figure through Jun 2026 stood at 12.68 (down 99.78% YoY), while the FY2024 annual figure was 78.36, changed N/A from the prior year.
• Price to Sales came in at 13.36 for Q1 2026 at vTv Therapeutics, down from 4687.79 in the prior quarter.
• In the past five years, Price to Sales ranged from a high of 8368.57 in Q2 2022 to a low of 13.36 in Q1 2026.
• Average Price to Sales over 3 years is 3483.54, with a median of 2392.62 recorded in 2024.
• The largest YoY upside for Price to Sales was 22.63% in 2022 against a maximum downside of 85.9% in 2022.
• Over 3 years, Price to Sales stood at 7701.55 in 2022, then slumped by 39.13% to 4687.79 in 2024, then plunged by 99.72% to 13.36 in 2026.
• Per Business Quant data, the three most recent Price to Sales figures were 13.36 in Q1 2026, 4687.79 in Q4 2024, and 97.45 in Q1 2024.